Literature DB >> 1718050

Structure of vitronectin and its biological role in haemostasis.

K T Preissner, D Jenne.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1718050

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  14 in total

1.  Quantitation of vitronectin in serum: evaluation of its usefulness in routine clinical practice.

Authors:  N A Boyd; A R Bradwell; R A Thompson
Journal:  J Clin Pathol       Date:  1993-11       Impact factor: 3.411

2.  The human complement regulatory factor-H-like protein 1, which represents a truncated form of factor H, displays cell-attachment activity.

Authors:  J Hellwage; S Kühn; P F Zipfel
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

Review 3.  Glycosaminoglycans and the regulation of blood coagulation.

Authors:  M C Bourin; U Lindahl
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

4.  The cluster of basic amino acids in vitronectin contributes to its binding of plasminogen activator inhibitor-1: evidence from thrombin-, elastase- and plasmin-cleaved vitronectins and anti-peptide antibodies.

Authors:  Z Gechtman; A Belleli; S Lechpammer; S Shaltiel
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

5.  Hysteresis as a Marker for Complex, Overlapping Landscapes in Proteins.

Authors:  Benjamin T Andrews; Dominique T Capraro; Joanna I Sulkowska; José N Onuchic; Patricia A Jennings
Journal:  J Phys Chem Lett       Date:  2012-12-18       Impact factor: 6.475

6.  Vitronectin inhibits efferocytosis through interactions with apoptotic cells as well as with macrophages.

Authors:  Hong-Beom Bae; Jean-Marc Tadie; Shaoning Jiang; Dae Won Park; Celeste P Bell; Lawrence C Thompson; Cynthia B Peterson; Victor J Thannickal; Edward Abraham; Jaroslaw W Zmijewski
Journal:  J Immunol       Date:  2013-01-23       Impact factor: 5.422

7.  Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells.

Authors:  T L Moser; J J Enghild; S V Pizzo; M S Stack
Journal:  Biochem J       Date:  1995-05-01       Impact factor: 3.857

Review 8.  Proteolysis and invasiveness of brain tumors: role of urokinase-type plasminogen activator receptor.

Authors:  S Mohanam; R E Sawaya; M Yamamoto; J M Bruner; G L Nicholson; J S Rao
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

9.  The significance of vitronectin in proliferative diabetic retinopathy.

Authors:  P Esser; M Bresgen; M Weller; K Heimann; P Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-08       Impact factor: 3.117

10.  Pseudomonas aeruginosa Uses Dihydrolipoamide Dehydrogenase (Lpd) to Bind to the Human Terminal Pathway Regulators Vitronectin and Clusterin to Inhibit Terminal Pathway Complement Attack.

Authors:  Teresia Hallström; Melanie Uhde; Birendra Singh; Christine Skerka; Kristian Riesbeck; Peter F Zipfel
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.